Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
FOCL
FocalTherics
$2.61
-7.4%
$4.05
$2.11
▼
$6.40
$97.95M-0.0290,602 shs120,132 shs
Inogen, Inc stock logo
INGN
Inogen
$5.31
-2.1%
$6.03
$5.05
▼
$7.67
$137.93M1.51295,961 shs266,097 shs
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
$1.49
-6.2%
$4.31
$1.48
▼
$35.29
$12.82M1.47112,955 shs49,394 shs
Neuronetics, Inc. stock logo
STIM
Neuronetics
$1.26
+1.2%
$2.21
$0.80
▼
$3.44
$97.55M1.362.14 million shs2.28 million shs
7 Stocks That Could Be Bigger Than Tesla, NVIDIA, and Google Cover

Could the next Tesla, NVIDIA, and Google be hiding in plain sight? Discover seven growth stocks with the potential to become tomorrow's market giants, fueled by breakthroughs in AI, nuclear energy, cybersecurity, and more.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
FOCL
FocalTherics
-9.03%-17.30%-32.86%-31.72%+281,999,900.00%
Inogen, Inc stock logo
INGN
Inogen
-2.69%-3.56%-18.98%-3.39%-18.98%
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
-7.02%+0.63%-69.83%-65.51%-95.05%
Neuronetics, Inc. stock logo
STIM
Neuronetics
-0.80%-13.29%-37.37%-58.67%-16.78%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
FOCL
FocalTherics
$2.61
-7.4%
$4.05
$2.11
▼
$6.40
$97.95M-0.0290,602 shs120,132 shs
Inogen, Inc stock logo
INGN
Inogen
$5.31
-2.1%
$6.03
$5.05
▼
$7.67
$137.93M1.51295,961 shs266,097 shs
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
$1.49
-6.2%
$4.31
$1.48
▼
$35.29
$12.82M1.47112,955 shs49,394 shs
Neuronetics, Inc. stock logo
STIM
Neuronetics
$1.26
+1.2%
$2.21
$0.80
▼
$3.44
$97.55M1.362.14 million shs2.28 million shs
7 Stocks That Could Be Bigger Than Tesla, NVIDIA, and Google Cover

Could the next Tesla, NVIDIA, and Google be hiding in plain sight? Discover seven growth stocks with the potential to become tomorrow's market giants, fueled by breakthroughs in AI, nuclear energy, cybersecurity, and more.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
FOCL
FocalTherics
-9.03%-17.30%-32.86%-31.72%+281,999,900.00%
Inogen, Inc stock logo
INGN
Inogen
-2.69%-3.56%-18.98%-3.39%-18.98%
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
-7.02%+0.63%-69.83%-65.51%-95.05%
Neuronetics, Inc. stock logo
STIM
Neuronetics
-0.80%-13.29%-37.37%-58.67%-16.78%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
FOCL
FocalTherics
2.50
Moderate Buy$9.67270.37% Upside
Inogen, Inc stock logo
INGN
Inogen
2.50
Moderate BuyN/AN/A
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
1.67
Reduce$47.003,052.25% Upside
Neuronetics, Inc. stock logo
STIM
Neuronetics
2.67
Moderate Buy$5.00298.41% Upside

Current Analyst Ratings Breakdown

Latest SNWV, INGN, FOCL, and STIM Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/18/2026
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
DowngradeSell (D+) ➝ Sell (D)
11/16/2026
Neuronetics, Inc. stock logo
STIM
Neuronetics
Initiated CoverageMarket Perform ➝ Outperform
11/9/2026
FOCL
FocalTherics
DowngradeSell (D-) ➝ Sell (E+)
11/6/2026
Neuronetics, Inc. stock logo
STIM
Neuronetics
Boost Price TargetBuy$5.00 ➝ $6.00
11/4/2026
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
UpgradeSell (D) ➝ Sell (D+)
11/3/2026
Inogen, Inc stock logo
INGN
Inogen
Reiterated RatingSell (D-)
10/23/2026
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
DowngradeSell (D+) ➝ Sell (D)
9/18/2026
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
DowngradeHold (C-) ➝ Sell (D+)
9/17/2026
Neuronetics, Inc. stock logo
STIM
Neuronetics
Reiterated RatingBuy$6.00
9/14/2026
Neuronetics, Inc. stock logo
STIM
Neuronetics
Reiterated RatingSell (E+)
9/11/2026
Neuronetics, Inc. stock logo
STIM
Neuronetics
Initiated CoverageBuy
(Data available from 11/20/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
FOCL
FocalTherics
$70.53M1.39N/AN/A$0.96 per share2.72
Inogen, Inc stock logo
INGN
Inogen
$348.67M0.40N/AN/A$6.04 per share0.88
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
$44.05M0.29$1.48 per share1.01$0.33 per share4.52
Neuronetics, Inc. stock logo
STIM
Neuronetics
$149.16M0.65N/AN/A$0.29 per share4.33
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
FOCL
FocalTherics
-$29.25M-$0.98N/AN/AN/A-59.77%-223.32%-41.32%N/A
Inogen, Inc stock logo
INGN
Inogen
-$22.75M-$1.31N/AN/AN/A-10.46%-19.29%-12.02%N/A
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
$11.81M-$0.38N/AN/AN/A6.22%113.13%7.17%N/A
Neuronetics, Inc. stock logo
STIM
Neuronetics
-$39M-$0.33N/AN/AN/A-14.45%-102.23%-16.83%N/A

Latest SNWV, INGN, FOCL, and STIM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/10/2026Q3 2026
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
$0.01-$0.16-$0.17-$0.16$13.75 million$8.58 million
11/5/2026Q3 2026
FOCL
FocalTherics
-$0.18-$0.10+$0.08-$0.10N/A$9.83 million
11/5/2026Q3 2026
Inogen, Inc stock logo
INGN
Inogen
-$0.1423-$0.56-$0.4177-$0.61$92.25 million$77.19 million
11/4/2026Q3 2026
Neuronetics, Inc. stock logo
STIM
Neuronetics
-$0.0873-$0.02+$0.0673-$0.02$40.43 million$41.96 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
FOCL
FocalTherics
N/AN/AN/AN/AN/A
Inogen, Inc stock logo
INGN
Inogen
N/AN/AN/AN/AN/A
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
N/AN/AN/AN/AN/A
Neuronetics, Inc. stock logo
STIM
Neuronetics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
FOCL
FocalTherics
0.98
2.63
2.40
Inogen, Inc stock logo
INGN
Inogen
N/A
2.96
2.55
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
4.01
1.18
0.77
Neuronetics, Inc. stock logo
STIM
Neuronetics
2.76
2.01
1.82

Institutional Ownership

CompanyInstitutional Ownership
FOCL
FocalTherics
62.74%
Inogen, Inc stock logo
INGN
Inogen
89.94%
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
42.53%
Neuronetics, Inc. stock logo
STIM
Neuronetics
53.59%

Insider Ownership

CompanyInsider Ownership
FOCL
FocalTherics
10.10%
Inogen, Inc stock logo
INGN
Inogen
2.50%
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
14.40%
Neuronetics, Inc. stock logo
STIM
Neuronetics
8.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
FOCL
FocalTherics
23037.53 million33.74 millionOptionable
Inogen, Inc stock logo
INGN
Inogen
75326.00 million25.35 millionOptionable
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
558.60 million7.36 millionN/A
Neuronetics, Inc. stock logo
STIM
Neuronetics
65877.73 million71.20 millionOptionable

Recent News About These Companies

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
William Blair Begins Coverage on Neuronetics (NASDAQ:STIM)
Neuronetics (NASDAQ:STIM) Now Covered by William Blair
Neuronetics stock prices USD 30 million public offering
Neuronetics stock: Q3 revenue rises as loss narrows
Neuronetics stock tumbles 10% on stock offering launch

New MarketBeat Followers Over Time

Media Sentiment Over Time

FocalTherics NASDAQ:FOCL

$2.61 -0.21 (-7.45%)
As of 03:46 PM Eastern

EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST). The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment also offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; Ablatherm Fusion that incorporates the company's proprietary fusion software, which merges MRI and ultrasound images; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology; and offers Sonolith i-move, an extracorporeal shockwave lithotripter to small and mid-size hospitals, as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. The company markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents. Its customers include hospitals, urology clinics, and research institutions. The company was incorporated in 1979 and is headquartered in Lyon, France.

Inogen stock logo

Inogen NASDAQ:INGN

$5.30 -0.12 (-2.12%)
Closing price 03:59 PM Eastern
Extended Trading
$5.30 0.00 (0.00%)
As of 04:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

Sanuwave Health stock logo

Sanuwave Health NASDAQ:SNWV

$1.49 -0.10 (-6.29%)
As of 04:00 PM Eastern
This is a fair market value price provided by Massive. Learn more.

SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures. The company's lead regenerative product is the dermaPACE device for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. In addition, it offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds; and orthoPACE system to treat tendinopathies and acute and nonunion fractures. The company was founded in 2005 and is headquartered in Suwanee, Georgia.

Neuronetics stock logo

Neuronetics NASDAQ:STIM

$1.25 +0.02 (+1.21%)
Closing price 03:58 PM Eastern
Extended Trading
$1.24 -0.01 (-1.04%)
As of 04:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.